CN.ORTH: Clinical Hold Lifted in Time for 3Q:22 Results
CN.ORTH: Clinical Hold Lifted in Time for 3Q:22 Results
CN.ORTH：3Q：22结果及时解除临床搁置
By John Vandermosten, CFA
约翰·范德莫斯滕(John Vandermosten)，CFA
CNSX:ORTH.CN | OTC:ORTIF
CNSX：ORTH.CN|场外交易：ORTIF
READ THE FULL ORTH.CN RESEARCH REPORT
阅读完整的ORTH.CN研究报告
Clinical Hold Letter Lifted
临床搁置信件解除
Following the April 2021 Investigational New Drug (IND) submission for Ortho-R, Ortho Regenerative Technologies Inc. (CSE:ORTH) (OTC:ORTIF) notified the public on December 13th that the FDA had lifted its Clinical Hold on the application. Two months after its IND submission, Ortho announced that a clinical hold had been placed on the trial launch pending the collection of additional chemistry, manufacturing and control (CMC) related data and characterization of the chitosan product. On July 20th, Ortho announced that it had formally...
根据2021年4月提交的Ortho-R研究新药(IND)，Ortho Regenerative Technologies Inc.(CSE：ORTH)(场外交易...
登录免费看全文
登录/注册